GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hyundai Bioscience Co Ltd (XKRX:048410) » Definitions » Institutional Ownership

Hyundai Bioscience Co (XKRX:048410) Institutional Ownership : 7.33% (As of Jun. 08, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Hyundai Bioscience Co Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Hyundai Bioscience Co's institutional ownership is 7.33%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Hyundai Bioscience Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Hyundai Bioscience Co's Float Percentage Of Total Shares Outstanding is 0.00%.


Hyundai Bioscience Co Institutional Ownership Historical Data

The historical data trend for Hyundai Bioscience Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyundai Bioscience Co Institutional Ownership Chart

Hyundai Bioscience Co Historical Data

The historical data trend for Hyundai Bioscience Co can be seen below:

2023-07-31 2023-08-31 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 6.77 6.87 7.29 7.28 7.29 7.37 7.36 7.26 7.33 7.33

Hyundai Bioscience Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Hyundai Bioscience Co (XKRX:048410) Business Description

Traded in Other Exchanges
N/A
Address
150 North-Ahyun Road, 3rd Floor Academic Cooperation Building, Ehwa Women’s University, Seodaemun-gu, Seoul, KOR
Hyundai Bioscience Co Ltd is a Korean biotechnology company. The company is engaged in developing and commercializing bio-fusion technology with the purpose of delivering active ingredients safely and efficiently to the body. It has developed Vitabrid CG, a biomaterial that binds vitamin C with bio-friendly mineral layers, which is a beneficial ingredient in skin brightening, anti-aging, and anti-inflammation; and Vitabrid C12, a premium skincare brand.

Hyundai Bioscience Co (XKRX:048410) Headlines

No Headlines